Видео ютуба по тегу Immune Checkpoint Resistance

Characterizing Mechanisms of Response and Resistance to Immune Checkpoint Inhibitor Therapy Using...
Characterizing Mechanisms of Response and Resistance to Immune Checkpoint Inhibitor Therapy Using...
Dr. Sharma Discusses Immune Checkpoint Resistance in GU Cancers
Dr. Sharma Discusses Immune Checkpoint Resistance in GU Cancers
Overcoming resistance to immune checkpoint inhibitors in NSCLC
Overcoming resistance to immune checkpoint inhibitors in NSCLC
Cancer Immune Checkpoint Inhibitors
Cancer Immune Checkpoint Inhibitors
Resistance to immune checkpoint blockade in patients with cSCC
Resistance to immune checkpoint blockade in patients with cSCC
«Механизмы ответа и резистентности к терапии иммунных контрольных точек» доктора Падмани Шармы
«Механизмы ответа и резистентности к терапии иммунных контрольных точек» доктора Падмани Шармы
Updates on Immune Checkpoint Blockade Resistant Melanoma
Updates on Immune Checkpoint Blockade Resistant Melanoma
Overcoming immune checkpoint inhibitor resistance in kidney cancer
Overcoming immune checkpoint inhibitor resistance in kidney cancer
Decoding Resistance to Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
Decoding Resistance to Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
Cross-resistance between targeted therapies and immune checkpoint inhibitors in melanoma
Cross-resistance between targeted therapies and immune checkpoint inhibitors in melanoma
June 7, 2021 | Investigating Mechanisms of Response & Resistance to Immune Checkpoint Therapy
June 7, 2021 | Investigating Mechanisms of Response & Resistance to Immune Checkpoint Therapy
CV Impact of Immune Checkpoint Inhibitor Cardiotoxicity
CV Impact of Immune Checkpoint Inhibitor Cardiotoxicity
Mechanisms of resistance to checkpoint inhibitors in melanoma
Mechanisms of resistance to checkpoint inhibitors in melanoma
(Overview) Molecular Tumor Board: Resistance to Checkpoint Inhibitors - Part 1
(Overview) Molecular Tumor Board: Resistance to Checkpoint Inhibitors - Part 1
Dissecting Toxicities of Immune Checkpoint Inhibitors with Dr. Douglas Johnson, M.D., MSCI
Dissecting Toxicities of Immune Checkpoint Inhibitors with Dr. Douglas Johnson, M.D., MSCI
Immunotherapy resistance mechanisms and predicting NMIBC patient immune responses.
Immunotherapy resistance mechanisms and predicting NMIBC patient immune responses.
New Insights on Acq. Resistance to Immune Checkpoint Inhibitors for NSCLC: Implications (BMIC-028)
New Insights on Acq. Resistance to Immune Checkpoint Inhibitors for NSCLC: Implications (BMIC-028)
Mechanisms resulting in resistance to checkpoint inhibitors in NSCLC
Mechanisms resulting in resistance to checkpoint inhibitors in NSCLC
Predicting response to checkpoint inhibitors and overcoming resistance in lung cancers
Predicting response to checkpoint inhibitors and overcoming resistance in lung cancers
(Overview) Molecular Tumor Board: Resistance to Checkpoint Inhibitors Part 2
(Overview) Molecular Tumor Board: Resistance to Checkpoint Inhibitors Part 2